Search Results - "E. G. Arshanskaya"

Thrombopoietin Receptor Agonists in the Treatment of Chronic Resistant Primary Immune Thrombocytopenia: Efficacy and Safety Data in Real Clinical Practice by Ptushkin, V V, Vinogradova, O Yu, Pankrashkina, M M, Chernikov, M V, Arshanskaya, E G, Tkachenko, N E

“…To analyze the long-term efficacy and safety of ATR in adult patients with primary resistant ITP in real-world clinical practice. The article contains…”
Get full text

Resolution of the Expert council “Unsolved problems of targeted therapy for paroxysmal nocturnal hemoglobinuria in Russia” by Kulagin, A. D., Lukina, E. A., Ptushkin, V. V., Kostinov, M. P., Arshanskaya, E. G., Babaeva, T. N., Ksenzova, T. I., Fidarova, Z. T., Marchenko, M. V.

“…   On June 24, 2023, an Expert Council was held in St. Petersburg, during which leading experts in the field of hematology discussed current achievements and…”
Get full text

Quality of life and socio-medical consequences in adolescent and young adult survivors following treatment for Hodgkin's lymphoma by Semochkin, S Y, Arshanskaya, E G, Sotnikov, V M, Rumyantsev, A G

“…Between 1997 and 2008, 97 adolescents and young adults with a median age 18.9 years (range, 15.0-33.6) with all stages Hodgkin's lymphoma (HL) were treated by…”
Get more information

Combination of bendamustine and rituximab in the management of relapsed and refractory chronic lymphocytic leukemia: the results of retrospective study by Semochkin, S. V., Arshanskaya, E. G., Zakharov, O. D., Kotelnikova, A. N., Kulikova, S. S., Ovanesova, E. V., Kochkareva, Yu. B., Ivanova, V. L.

“…Efficacy and safety results of rituximab and bendamustine combination (Scheme BR) in patients with relapsed and refractory chronic lymphocytic leukemia (CLL)…”
Get full text

Combination of bendamustine and rituximab in the management of relapsed and refractory chronic lymphocytic leukemia: the results of retrospective study by S. V. Semochkin, E. G. Arshanskaya, O. D. Zakharov, A. N. Kotelnikova, S. S. Kulikova, E. V. Ovanesova, Yu. B. Kochkareva, V. L. Ivanova

“…Efficacy and safety results of rituximab and bendamustine combination (Scheme BR) in patients with relapsed and refractory chronic lymphocytic leukemia (CLL)…”
Get full text